Back to search

Performance of the Abbott RealTime HCV Genotype II RUO Assay

Data up to Jan 2025

Published2012
Citations18
References14

Total Citations Per Year

Abstract

References (14)

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

1999 • 3,083 citations

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

2011 • 2,514 citations

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

2011 • 2,404 citations

The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

2006 • 1,978 citations

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

2011 • 1,612 citations

Telaprevir for Retreatment of HCV Infection

2011 • 1,559 citations

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing

1995 • 229 citations

Elevated prevalence of hepatitis C infection in users of United States veterans medical centers

2005 • 212 citations

Management and Treatment of Hepatitis C Viral Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office

2006 • 169 citations

Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients

2011 • 97 citations

Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office

2012 • 83 citations

A multicenter evaluation of the Abbott RealTime HCV Genotype II assay

2010 • 31 citations

Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping

2010 • 18 citations

Natural history of hepatitis C infection: a concise review.

2001 • 13 citations

Cited By (0)

No citing papers found in database

Performance of the Abbott RealTime HCV Genotype II RUO Assay (2012) – Journal of Clinical Microbiology | Metascience Observatory Explorer